4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

Patients with cardiac diseases or conditions with high risk of developing cardiac diseases
undergo risk assessment by cardiologists, primary care physicians, and scientists based on …

Sinus node dysfunction may be either transient (reversible/physiological) due to the
involvement of the autonomic nervous system or pharmaceuticals, or chronic due to …

Premature ventricular contraction (PVC), a common arrhythmia affecting 1–2% of the
general population, has been considered to have a benign clinical course. However, people …

Background No independently validated score currently exists for risk stratification of
patients with frequent premature ventricular complexes (PVCs). Objectives The purpose of …

Objectives This study sought to assess the rate and outcomes of premature ventricular
contractions (PVC)–cardiomyopathy from the CHF-STAT (Survival Trial of Antiarrhythmic …

Clinically silent cardiac disease is frequently observed in rheumatoid arthritis (RA), and
cardiovascular complications are the leading cause of mortality in RA. We sought to …

There is variability in treatment modalities for premature ventricular complexes (PVCs),
including use of antiarrhythmic drug (AAD) therapy or catheter ablation (CA). This study …

Abstract Aims Premature ventricular contractions (PVCs) are a common form of arrhythmia
associated with an unfavourable prognosis in patients with structural heart disease …

Objective A higher premature ventricular complex (PVC) frequency is associated with
incident congestive heart failure (CHF) and death. While certain PVC characteristics may …